GCP
NAUT icon

Gill Capital Partners’s Nautilus Biotechnolgy NAUT Stock Holding History

Gill Capital Partners’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$970 Buy
+250
New +$614 ﹤0.01% 600

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Gill Capital Partners's NAUT Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Nautilus Biotechnolgy (NAUT) in Q1 2026: 250 shares worth $970. The stake represents ﹤0.01% of the portfolio and ranks #600 among its holdings.

81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Gill Capital Partners held 250 shares of Nautilus Biotechnolgy worth $970 as of Q1 2026.
  • Nautilus Biotechnolgy was a new Gill Capital Partners position in Q1 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #600 holding.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.